Management of Elevated Insulin and Metabolic Risk in Adolescents

Interpretation of Fasting Insulin

The American Heart Association defines fasting insulin < 15 mU/L as normal, 15‑20 mU/L as borderline high, and > 20 mU/L as high, guiding risk assessment for insulin resistance. 1

Calculate body‑mass index and classify as overweight (≥ 85th percentile) or obesity (≥ 95th percentile) to identify youth at metabolic risk. 1
Measure blood pressure using age‑, sex‑, and height‑specific percentiles to detect hypertension associated with insulin resistance. 1

Obtain a fasting lipid panel (triglycerides, HDL‑C, LDL‑C) to screen for dyslipidemia that commonly co‑exists with insulin resistance. 1
Perform fasting plasma glucose to identify impaired fasting glucose or overt diabetes. 1
Order hemoglobin A1c when glucose abnormalities are suspected, providing an additional marker of chronic glycemia. 5

Document family history of type 2 diabetes in first‑ or second‑degree relatives, a strong predictor of future disease. 1
Record race/ethnicity (e.g., American Indian, African American, Hispanic, Asian/Pacific Islander) because these groups have higher prevalence of insulin resistance. 1
Assess physical activity levels, as low activity contributes to worsening insulin sensitivity. 1

Look for acanthosis nigricans—dark, velvety hyperpigmentation in skin folds—as a hallmark sign of insulin resistance. 1
Measure waist circumference and waist‑to‑hip ratio to evaluate central adiposity, a key component of metabolic syndrome. 1
Screen for signs of polycystic ovary syndrome (hirsutism, irregular menses, acne) that often accompany hyperinsulinemia in adolescents. 1
Evaluate for other endocrine disorders such as Cushing’s syndrome that can mimic or exacerbate insulin resistance. 1

Even with decreasing insulin levels, the presence of obesity, hypertension, or dyslipidemia independently raises cardiovascular disease risk and warrants aggressive management. 1

For youth with BMI ≥ 85th percentile, aim to achieve and maintain BMI < 95th percentile through structured weight‑management programs. 5

Implement a family‑centered diet that reduces simple sugars, controls portion sizes, and eliminates high‑calorie foods from the home environment. 4

Follow the American Diabetes Association recommendation of ≥ 60 minutes of moderate‑to‑vigorous aerobic activity daily, plus muscle‑strengthening and bone‑strengthening exercises on at least three days per week. 8

Use family‑based behavioral interventions that engage all overweight family members and employ positive reinforcement rather than criticism. 4

Reassess blood pressure, fasting glucose, lipid profile, and fasting insulin periodically to track metabolic trends. 1
Record BMI at every clinical encounter to monitor weight trajectory. 2
Remain vigilant for progression to impaired glucose tolerance or overt type 2 diabetes, initiating further evaluation if detected. 1

Recognize that normal puberty induces a transient physiological insulin resistance that peaks in mid‑puberty and resolves by the end of puberty; differentiate this from pathological insulin resistance. 9

Refer to pediatric endocrinology, lipid specialists, or obesity clinics when metabolic syndrome is identified or multiple risk factors coexist. 1
No pharmacologic agents for weight control or insulin resistance have demonstrated safety and efficacy in children outside of established diabetes treatment; lifestyle modification remains the evidence‑based cornerstone. 4

Strength of evidence: Not explicitly graded in the cited sources; recommendations are derived from consensus guidelines and observational data.